在软组织肉瘤中使用新辅助或辅助化疗?
Piotr Remiszewski1,2, Kinga Filipek1,3, Agata Pisklak1,3
1Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Current oncology reports
|March 28, 2025
概括
新辅助化疗 (NAC) 改善了软组织瘤 (STS) 的瘤切除,而外科手术期间的化疗显示出混合的结果. 诺米图有助于识别从化疗中受益的STS患者,特别是那些生存预测较低的患者.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 医学瘤学 医学瘤学
背景情况:
- 软组织肉瘤 (STS) 治疗涉及关于新辅助 (手术前) 和辅助 (手术后) 化疗的有争议的方法.
- 最近的研究和指导方针提供了关于术后化疗在STS管理中的作用的不断变化的观点.
研究的目的:
- 为了比较新辅助化疗 (NAC) 与辅助化疗 (AC) 在软组织肉瘤 (STS) 的有效性.
- 审查当前证据和关于STS的术后化疗的指南.
主要方法:
- 关于最近的研究和临床试验的文献评论 (例如,EORTC 62,771,EORTC 62,931,ISG-STS 1001,PERSARC).
- 分析像Sarculator这样的nomograms来预测患者从外科手术期间的化疗中获益.
- 评估关于STS治疗的欧洲指导方针.
主要成果:
- 新辅助化疗 (NAC) 增强了完整的瘤切除率 (R0切除),特别是在大型,高等级的STS中,可能降低了手术致病率.
- 术后化疗,特别是 antracycline 和 ifosfamide (AI) 疗法,对无复发生存率 (RFS) 和整体生存率 (OS) 产生可变的影响.
- 诺莫图和聚合分析表明,人工智能化疗可能有利于预测总生存率低的STS患者 (OS <60%或5年OS<33%),特别是那些R1切除患者.
结论:
- 新辅助化疗 (NAC) 有助于改善STS的外科治疗结果.
- 在STS中术后化疗 (AI疗法) 的作用仍然存在争议,有证据表明,通过名图识别的特定患者群体的生存益处.
- 需要进一步的研究来澄清不同STS亚型和风险概况的最佳化疗策略.
相关概念视频
02:49Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
02:56Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
01:27Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K